Press Release Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer Aug 12
Press Release Integra Strengthens Long-Term Growth Strategy in Australia and New Zealand with the Appointment of Mark Thompson as Managing Director Aug 12
Press Release Joybound People & Pets Announces Three New Board Members to Support Continued Growth and Impact Aug 12
Press Release Mobilewalla and SPACSphere Acquisition Corp. Announce Filing of Registration Statement on Form S-4 Regarding Proposed Business Combination Aug 12